Our Services
We provide a comprehensive array of financial services to a diverse range of corporate clients, institutional investors, and high net worth investors.
Investment Banking
Equity Research
Capital Markets
Merchant Capital
Wealth Management
Prime Brokerage
Recent
Transactions
Over 180 financings and $23.5 Billion in aggregate as Lead, Joint, or Co-Manager in 2021

Up to $9.8 Million
PIPE
// Sole Placement Agent
March 2023



$8.0 Million
Registered Direct Offering
// Sole Placement Agent
March 2023














Up to $130 Million
PIPE
// Financial Advisor
March 2023














$12.5 Million
Registered Direct
// Sole Placement Agent
March 2023












![[www.maximgrp.com][679]logo-contrafect [www.maximgrp.com][679]logo-contrafect](https://www.maximgrp.com/wp-content/uploads/elementor/thumbs/www.maximgrp.com679logo-contrafect-ovp6abpwk6arkjpakeu1hl7yuls4g5h4tiqsi52ww0.jpg)
![[www.maximgrp.com][679]logo-contrafect [www.maximgrp.com][679]logo-contrafect](https://www.maximgrp.com/wp-content/uploads/elementor/thumbs/www.maximgrp.com679logo-contrafect-ovp6abpwk6arkjpakeu1hl7yuls4g5h4tiqsi52ww0.jpg)
$10.0 Million
Registered Direct Offering
// Sole Placement Agent
February 2023














$5.0 Million
Registered Direct
// Sole Placement Agent
February 2023














$5.5 Million
CMPO
// Sole Book-Running Manager
February 2023














$7.0 Million
Follow-On Offering
// Co-Placement Agent
February 2023














$13.0 Million
Follow-On Offering
// Sole Placement Agent
February 2023














$60.0 Million
Initial Public Offering
// Sole Book-Running Manager
February 2023














$13.6 Million
Registered Direct Offering
// Sole Placement Agent
February 2023












Upcoming Events
Maxim Group events are hosted on our digital platform, M-Vest
Merchant Capital
Maxim Merchant Capital’s skilled specialists have significant experience in raising private capital for both late-stage and early-stage private and public companies across a range of industries; predominantly in life sciences/biotechnology. Within the biotech sector, we look for companies that address significant unmet needs and have a clear regulatory path.